Ratings by Barclays (Gena Wang)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/14/2021 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details
8/11/2021 Sigilon Therapeutics SGTX Maintain Overweight
(N/A)
 
 
  Details
8/11/2021 Beam Inc BEAM Maintain Equalweight
(N/A)
 
 
  Details
8/10/2021 Kodiak Sciences Inc. KOD Maintain Underweight
(N/A)
 
 
  Details
8/10/2021 Arcturus Therapeutics ARCT Maintain Underweight
(N/A)
 
 
  Details
8/6/2021 Vir Biotechnology VIR Maintain Overweight
(N/A)
 
 
  Details
8/6/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
8/6/2021 BioCryst Pharma BCRX Maintain Overweight
(N/A)
 
 
  Details
8/5/2021 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
8/4/2021 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
6/21/2021 Arcturus Therapeutics ARCT Downgrade Underweight
(Equalweight)
33.89
(54.45)
60.67% Details
6/11/2021 Vertex VRTX Maintain Overweight
(N/A)
 
 
  Details
5/17/2021 Solid Biosciences SLDB Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
5/7/2021 BioCryst Pharma BCRX Maintain Overweight
(N/A)
 
 
  Details
5/5/2021 PTC Therapeutics PTCT Maintain Equalweight
(N/A)
 
 
  Details
3/23/2021 Ionis Pharmaceuticals IONS Maintain Equalweight
(N/A)
 
 
  Details
3/19/2021 Idera Pharmaceuticals IDRA Downgrade Equalweight
(Overweight)
5.13
(1.02)
-80.12% Details
3/9/2021 Decibel Therapeutics Inc DBTX New Coverage Overweight
(N/A)
14.68
(8.33)
-43.26% Details
3/9/2021 Solid Biosciences SLDB New Coverage Overweight
(N/A)
9.40
(2.80)
-70.21% Details
3/9/2021 Avrobio Inc. AVRO New Coverage Overweight
(N/A)
11.32
(6.18)
-45.41% Details
3/1/2021 Ionis Pharmaceuticals IONS Upgrade Equalweight
(Underweight)
53.41
(37.21)
-30.33% Details
3/1/2021 Editas Medicine EDIT Downgrade Equalweight
(Overweight)
44.76
(63.20)
41.2% Details
3/1/2021 Beam Inc BEAM Downgrade Equalweight
(Overweight)
88.52
(102.91)
16.26% Details
3/1/2021 Kodiak Sciences Inc. KOD Downgrade Underweight
(Equalweight)
121.08
(102.75)
-15.14% Details
2/26/2021 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
2/26/2021 BioCryst Pharma BCRX Maintain Overweight
(N/A)
 
 
  Details
2/25/2021 Vir Biotechnology VIR Maintain Overweight
(N/A)
 
 
  Details
2/12/2021 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
1/8/2021 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
12/29/2020 Arcturus Therapeutics ARCT Downgrade Equalweight
(Overweight)
98.13
(54.45)
-44.51% Details
12/29/2020 Sigilon Therapeutics SGTX New Coverage Overweight
(N/A)
41.20
(6.11)
-85.17% Details
12/18/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
11/6/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
11/6/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
9/24/2020 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details
8/14/2020 Precision BioSciences Inc. DTIL Maintain Overweight
(N/A)
 
 
  Details
8/12/2020 Vir Biotechnology VIR Maintain Overweight
(N/A)
 
 
  Details
8/11/2020 Kodiak Sciences Inc. KOD Maintain Equalweight
(N/A)
 
 
  Details
8/7/2020 Orchard Therapeutics ORTX Maintain Overweight
(N/A)
 
 
  Details
8/7/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
8/6/2020 Moderna MRNA Maintain Overweight
(N/A)
 
 
  Details
8/5/2020 BioMarin Pharmaceutical Inc. BMRN Maintain Overweight
(N/A)
 
 
  Details
6/8/2020 Moderna MRNA New Coverage Overweight
(N/A)
58.19
(430.05)
639.04% Details
5/13/2020 Vir Biotechnology VIR Maintain Overweight
(N/A)
 
 
  Details
5/7/2020 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
5/5/2020 BioCryst Pharma BCRX Upgrade Overweight
(Equalweight)
3.93
(15.70)
299.49% Details
3/2/2020 Beam Inc BEAM New Coverage Overweight
(N/A)
22.93
(102.91)
348.8% Details
2/18/2020 Eidos Therapeutics EIDX Downgrade Underweight
(Equalweight)
53.86
(122.21)
126.9% Details
2/18/2020 Kodiak Sciences Inc. KOD Downgrade Equalweight
(Overweight)
62.77
(102.75)
63.69% Details
11/27/2019 BioMarin Pharmaceutical Inc. BMRN Upgrade Overweight
(Equalweight)
78.51
(77.76)
-0.96% Details
11/21/2019 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
11/7/2019 Puma Biotechnology PBYI Maintain Underweight
(N/A)
 
 
  Details
11/5/2019 Halozyme Therapeutics HALO Upgrade Equalweight
(Underweight)
15.55
(42.04)
170.35% Details
11/5/2019 Vir Biotechnology VIR New Coverage Overweight
(N/A)
15.00
(54.54)
263.6% Details
11/1/2019 Eidos Therapeutics EIDX Downgrade Equalweight
(Overweight)
47.40
(122.21)
157.83% Details
10/24/2019 BioMarin Pharmaceutical Inc. BMRN Maintain Equalweight
(N/A)
 
 
  Details
9/5/2019 Orchard Therapeutics ORTX New Coverage Overweight
(N/A)
14.70
(2.82)
-80.82% Details
8/9/2019 Puma Biotechnology PBYI Maintain Underweight
(N/A)
 
 
  Details
8/2/2019 Clovis Oncology CLVS Maintain Overweight
(N/A)
 
 
  Details
4/22/2019 Precision BioSciences Inc. DTIL New Coverage Overweight
(N/A)
12.18
(12.86)
5.58% Details
3/25/2019 Nightstar Therapeutics NITE Downgrade Equalweight
(Overweight)
25.31
(25.41)
0.4% Details
3/25/2019 Spark Therapeutics ONCE Downgrade Equalweight
(Overweight)
113.27
(110.05)
-2.84% Details
2/28/2019 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
2/19/2019 Spark Therapeutics ONCE Maintain Overweight
(N/A)
 
 
  Details
12/18/2018 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details
12/17/2018 Nightstar Therapeutics NITE New Coverage Overweight
(N/A)
11.59
(25.31)
118.38% Details
12/10/2018 Tesaro TSRO Downgrade Equalweight
(Overweight)
73.78
(74.96)
1.6% Details
11/13/2018 LogicBio Therapeutics LOGC New Coverage Overweight
(N/A)
15.11
(4.65)
-69.23% Details
11/8/2018 Alnylam Pharmaceuticals ALNY Maintain Overweight
(N/A)
 
 
  Details
11/6/2018 PTC Therapeutics PTCT Maintain Equalweight
(N/A)
 
 
  Details
11/2/2018 Puma Biotechnology PBYI Downgrade Underweight
(Equalweight)
37.05
(6.90)
-81.38% Details
10/31/2018 Clovis Oncology CLVS Maintain Overweight
(N/A)
 
 
  Details
10/29/2018 Kodiak Sciences Inc. KOD New Coverage Overweight
(N/A)
9.56
(102.75)
974.79% Details
9/24/2018 Idera Pharmaceuticals IDRA New Coverage Overweight
(N/A)
8.32
(1.02)
-87.74% Details
9/21/2018 Sarepta Therapeutics SRPT Maintain Overweight
(N/A)
 
 
  Details
8/13/2018 Regenxbio Inc. RGNX Maintain Overweight
(N/A)
 
 
  Details